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Non-Hodgkin lymphoma of the extra hepatic bile ducts is extremely rare, more often it is a result of a secondary 
involvement in the systemic disease. In the Pub Med database we found only 7 reports presenting primary 
diffuse large B cell lymphoma of the common bile duct. 
We present a case of 56 years old male patient with an intramural lesion of the common bile duct that was found 
while performing cholecystectomy for cholelithiasis. Consequently resection of the common bill duct with 
Roux-en-Y hepaticojejunostomy was performed. The histopathology examination and Immunohistochemical 
staining revealed primary diffuse large cell B lymphoma of the common bile duct. The patient was referred to an 
oncology institution and was submitted to a combination chemotherapy using the R-CHOP protocol (Rituximab, 
Cyclophosphamide, Hydroxydaunorubicin, Oncovin and Prednisone). 
Primary lymphoma of the common bile duct is rare, but it should be considered as a differential diagnosis in 
extra hepatic bile duct obstruction. The histopathology finding is usually obtained from a surgical specimen and 
it is crucial for patients to receive adequate cancer th rapy. Yet the best treatment modality is still to be defined. 
 





Non-Hodgkin lymphomas (NHL) originate from 
lymphoid tissues and are result of chromosomal 
translocations, infections- immunodeficiency states, 
environmental factors or chronic inflammation. 
Clinical manifestations of NHL, especially with 
primary extra nodal involvement, are uncommon and 
depend on factors as the location of the process, rate 
of tumour growth and the function of the involved 
organ [1].  
Non-Hodgkin lymphoma (NHL) of the extra hepatic   
bile ducts is rare, we searched the Pub Med database 
and we found 34 published cases of NHLinvolving 
extra hepatic bile ducts , fist been published 1982 [2] 
and the last 2014 [3]. Clinical presentation varied 
from bile duct obstruction to cholecystitis in most 
presented cases. Histological presentation was diverse 
including many of NHL described for the first time in 
the gold bladder and bile ducts.     Only    7  reports 
were  presenting   primary extra hepatic bile duct 











diffuse large B-cell lymphoma [4-10], classified 
according to WHO (World Health Organization) [11].  
 
We describe a primary diffuse large B cell lymphoma 
found during elective cholecystectomy. 
 
2. MATERIALS AND METHODS  
 
Laboratory investigations were performed on 
АRCHITECT plus/C4000/Abbott analyzer. 
 
Pathology specimen was prepared with 10% neutral 
formalin, fixated with alcohol in paraffin blocks, 
hematoxylin-eosin and Giemsa staining was 
performed.  
 
Immunohistochemistry was performed with 
monoclonal antibodies for   CD20, CD79a CD3, 
CD45 i Ki-67, anti-CD20 mouse monoclonal antibody 
(DAKO clone L26, dilution 1:400), anti CD79a  
mouse monoclonal antibody (DAKO clone ICB117  
dilution 1:100) anti-CD3 mouse monoclonal antibody 
(DAKO clone  F7.2.38  dilution 1:100), anti CD45 
mouse monoclonal antibody (DAKO clone 
2B11+PD7/26  dilution 1:300) i  anti Ki-67 mouse 
monoclonal antibody ( DAKO clone MIB-1 dilution 
1:150). 
 
Visualisation was performed with modified Avidin-
Biotin Imunoperoxidase Complex method, with 
EnVision (Dako Denmark) system.   
 
Secondary cholangiography was performed on 
Siemens Axiom/Icons MD fluoroscope using 
Ultravist ®-370 (Bayer) contrast.  
 
3. CASE REPORT 
 
We present a case of 56 yeas old male patient with 
symptoms of cholecystitis. On several ultrasound 
examinations gall bladder stones were confirmed with 
no bile duct involvement and a mild elevation of AST 
(aspartate aminotransferase) 75 U/L, ALT (alanine 
aminotransferase) 64 U/L, GGT (gamma glutamyl 
transpeptidase)  164 U/L, AF (alkaline phosphatase)  
150 U/L and bilirubin 28 µmol/L  was present during  
one acute attack of cholecystits 6 months before the 
operation.  Open cholecystectomy was performed and 
on exploration an intramural 1-1.5 cm tumor 
formation on the posterior wall of the CBD (Common 
Bile Duct) opposite to the insertion of the cystic duct 
was found. The CBD with the tumor were mobilized, 
tumor occupies the posterior wall of the CBD 
encircling more than one half with no lymph node 
involvement. Choledohotomy was performed, there 
was no involvement of the mucosa with smooth 
partial obstruction of the CBD, needle biopsy trough 
the lumen was done and external drainage with T tube 
drain was placed. Post operative period was 
uneventful, patient discharged 6 POD (post operative 
day), secondary cholagiografy trough T tube drain 
was performed on 14POD (Fig. 1) and the drain was 
occluded for 4 weeks. Biopsy confirmed bile duct 
wall and inflammation, CT of the chest and abdomen 
was performed 1 month after the first operation and 
confirmed the tumor formation in the wall of the CBD 




Fig. 1. Secondary cholangiography.  
Cholangiografy performed on 14POD trough 
inserted T tube drain opposite the intramural 
tumour (arrowhead) with a slight dilatation of the 




Fig. 2. Computed tomography.  
Performed 6 weeks after the first operation, 
showing the tumour in the posterior wall of the 












Six weeks after the first operation second was 
performed consisting of resection of the CBD with 
Roux-en-Y hepaticojejunostomy. Post operative 
period was again uneventful, patient discharged 8 
POD.  
 
Histopathology examination revealed lymphoid cell 




Fig. 3. Histopathology with  hematoxylin and eosin 
staining. 100x magnification.  
Pseudo nodular lymphoid cell infiltration by large 
neoplastic cells with partial involvement of 
epithelial glandular structures. Peripheral 




Fig. 4. Giemsa staining. 100x magnification.  
Large neoplastic cells in nodular pattern               
with peripheral reactive infiltration by small 
lymphocytes 
 
Immunohistochemical staining was positive for LCA 
(leucocyte common antigen also known as CD45), 
CD20 (Fig. 5), CD79a, Ki-67, CD3 positivity on the 
surrounding- residual population of T- lymphocyte. 
 
Primary diffuse large B cell lymphoma (DLBCL) in 




Fig. 5. Imunohistochemical staining for CD20. 
(EnVision Flex; DAKO).  
200x magnification.  Diffuse membranous 
positivity in virtually all of the large neoplastic 
cells (DLBCL) 
 
The patient was referred to oncology institution and 
was submitted to a combination chemotherapy     
using the R-CHOP protocol (Rituximab, 
Cyclophosphamide, Hydroxydaunorubicin, Oncovin 
and Prednisone). Till the date of writing the paper the 
patient has finished 6th cycle of chemotherapy and had 
CT scan of the chest and abdomen with no evidence 




NHL is the most common hematologic malignancy, in 
the US they represent 4% of all malignancies and 
DLBCL (Diffuse Large B-Cell Lymphoma) is the 
most common histology with 23-35% of all new cases 
annually [12]. 
 
Bile duct obstruction by NHL accounts for 1-2% of 
all malignant obstructions. It is usually as a result of 
secondary involvement of the extra hepatic bile ducts 
by a systemic disease [4].  A case of primary DLBCL 
of the CBD is extremely rare, from the Pub Med 
database search we found only 7 cases reported and 
from the Macedonian registry of histopathology this is 
the only case reported in Macedonia.  
 
Pre operative diagnosis of primary lymphoma of the 
CBD and differentiation from other malignant bile 











suspected   diagnosis was of an epithelial origin bile 
duct malignancy, and the definitive diagnosis was 
performed on a surgical specimen. In same cases 
possibility of primary bile duct lymphoma should 
raise when obstructing mass shows smooth, mild 
luminal narrowing of the extra hepatic ducts without 
mucosal irregularities [13]. 
 
In our case the suspicious lesion was                   
identified intra operative and it was obvious that it did 
not originate from bile duct mucosa. The definitive 
diagnosis was obtained after surgical resection; this 
enabled the patient to receive specific chemotherapy 
treatment. 
 
Primary DLBCL of the CBD is rear and there is no 
consensus on treatment modality, surgical resection in 
all known cases was adequate in removing the 
lymphoma and establishing histopathology diagnosis 
[14]. Differentiating it from radio and chemo resistant 
bile duct malignancies enables patients to receive 
personalized cancer medicine and molecularly 




In conclusion primary lymphoma of the                              
CBD is extremely rare, but it should be                            
considered as a differential diagnosis in cases with 
extra hepatic bill duct obstruction. The histopathology 
finding is usually obtained from a surgical specimen 
and it is crucial for patients to receive adequate cancer 





The patient has given a written consent which will be 
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